These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 825589)

  • 61. Amikacin sulfate in mares: pharmacokinetics and body fluid and endometrial concentrations after repeated intramuscular administration.
    Brown MP; Embertson RM; Gronwall RR; Beal C; Mayhew IG; Curry SH
    Am J Vet Res; 1984 Aug; 45(8):1610-3. PubMed ID: 6476574
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of 'high-dose' amikacin in children.
    Kumor KM; McDonald JM; Lietman PS
    Dev Pharmacol Ther; 1984; 7(6):368-76. PubMed ID: 6518944
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Amikacin in gram-negative paediatric infections.
    Trujillo H; Manotas R; Ramirez JI; Uribe A; Agudelo N; Zapata CT; Zuluaga AI; de Vidal EL
    J Int Med Res; 1978; 6(4):257-65. PubMed ID: 357227
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
    Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J
    Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical pharmacokinetics of amikacin in dogs.
    Baggot JD; Ling GV; Chatfield RC
    Am J Vet Res; 1985 Aug; 46(8):1793-6. PubMed ID: 4037511
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical and bacteriological evaluation of amikacin in severe gram-negative infections.
    Klastersky J; Van Beerse D; Schoutens E; De Temmerman P; Yourassowsky E
    J Clin Pharmacol; 1976 Apr; 16(4):213-22. PubMed ID: 770510
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gram negative bone and joint infection: sixty patients treated with amikacin.
    Schurman DJ; Wheeler R
    Clin Orthop Relat Res; 1978; (134):268-74. PubMed ID: 365414
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa.
    Bayer AS; Kim KS
    Chemotherapy; 1986; 32(4):364-73. PubMed ID: 2942342
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacological evaluation of amikacin in neonates.
    Howard JB; McCracken GH
    Antimicrob Agents Chemother; 1975 Jul; 8(1):86-90. PubMed ID: 1164009
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Clinical experience of amikacin treatment in infantile bacterial infections (author's transl)].
    Chiba S
    Jpn J Antibiot; 1974 Jun; 27(3):389-91. PubMed ID: 4436952
    [No Abstract]   [Full Text] [Related]  

  • 71. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Sklaver AR; Greenman RL; Hoffman TA
    Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacology of amikacin in humans.
    Bodey GP; Valdivieso M; Feld R; Rodriguez V
    Antimicrob Agents Chemother; 1974 May; 5(5):508-12. PubMed ID: 4462465
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Experience of amikacin intravenous drip infusion (author's transl)].
    Tsuchiya J; Miyao S; Shinonome S; Takakuwa M; Mou M
    Jpn J Antibiot; 1980 Jul; 33(7):711-5. PubMed ID: 6935444
    [No Abstract]   [Full Text] [Related]  

  • 74. [Experimental and clinical studies of intravenous infusion of amikacin in acute respiratory tract infections].
    Ito T
    Jpn J Antibiot; 1982 Aug; 35(8):2111-25. PubMed ID: 7154253
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections.
    Giamarellou H; Yiallouros K; Petrikkos G; Moschovakis E; Vavouraki E; Voutsinas D; Sfikakis P
    J Antimicrob Chemother; 1991 May; 27 Suppl C():73-9. PubMed ID: 1906864
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Successful treatment of multiresistant pseudomonas peritonitis with combination of azlocillin and amikacin.
    Leung AC; Gribben J; Sleigh JD; Boulton Jones JM
    Scott Med J; 1983 Jan; 28(1):69-70. PubMed ID: 6403983
    [No Abstract]   [Full Text] [Related]  

  • 77. Amikacin therapy of serious gram-negative bacillary infections in chronic hemodialysis patients.
    Meyer RD; Lewis RP; Finegold SM
    Chemotherapy; 1978; 24(3):172-8. PubMed ID: 657877
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Clinical experience with amikacin for chronic complicated urinary tract infections in myelopathogenic bladder. Clinical effect against gentamicin-resistant bacteria (author's transl)].
    Konya H; Kuroda J; Iwao N; Morita M
    Jpn J Antibiot; 1978 Jul; 31(7):341-5. PubMed ID: 691255
    [No Abstract]   [Full Text] [Related]  

  • 79. Amikacin + ceftazidime therapy of experimental right-sided Pseudomonas aeruginosa endocarditis in rabbits.
    Bayer AS; Lam K; Norman D; Kim KS; Morrison JO
    Chemotherapy; 1985; 31(5):351-61. PubMed ID: 3931992
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Penetration of amikacin into the aphakic eye.
    Kasbeer RT; Peyman GA; May DR; Homer PI
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975 Aug; 196(1):85-94. PubMed ID: 1080641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.